Metformin-capped silver nanoparticles
Intervention1 paper4 findings
- Animals1
Outcomes
4Pyroptosis
downin human cells1Very low certainty
1 study
Pyroptosis
downin human cells1Very low certainty
Metformin-capped silver nanoparticles inhibit pyroptosis in human cells.
Cellsin KGN cells treated with macrophage conditioned medium
Targeting the macrophage-NLRP3 inflammasome-pyroptosis axis: Metformin-capped silver nanoparticles as a novel therapy for premature ovarian insufficiency · International immunopharmacology · 30 Aug 2026
NLRP3 inflammasome
downin rats1Very low certainty
1 study
NLRP3 inflammasome
downin rats1Very low certainty
Metformin-capped silver nanoparticles inhibit NLRP3 inflammasome in rats.
Animalsin POI rats
Targeting the macrophage-NLRP3 inflammasome-pyroptosis axis: Metformin-capped silver nanoparticles as a novel therapy for premature ovarian insufficiency · International immunopharmacology · 30 Aug 2026
Fertility
upin rats1Very low certainty
1 study
Fertility
upin rats1Very low certainty
Metformin-capped silver nanoparticles improve fertility in rats.
Animalsin POI rats
Targeting the macrophage-NLRP3 inflammasome-pyroptosis axis: Metformin-capped silver nanoparticles as a novel therapy for premature ovarian insufficiency · International immunopharmacology · 30 Aug 2026
Premature ovarian insufficiency
downin rats1Very low certainty
1 study
Premature ovarian insufficiency
downin rats1Very low certainty
Metformin-capped silver nanoparticles decrease premature ovarian insufficiency in rats.
Animalsin POI rats
Targeting the macrophage-NLRP3 inflammasome-pyroptosis axis: Metformin-capped silver nanoparticles as a novel therapy for premature ovarian insufficiency · International immunopharmacology · 30 Aug 2026